top of page
Science & Pipeline
Our Process
Our Process
Phase 01-
Discover
-
Exhaustive literature search, big data, and patient registries
-
Collaboration with research institutions and KOLs in the formation of new subsidiaries
Phase 02-
De-Risk
-
Find well-described, high unmet-need diseases that are ripe for intervention
-
Operate with world-class R&D; capabilities and personnel that have developed significant, marketed products
-
Employ a scale-able and low-cost corporate structure
Phase 03-
Develop
-
Build teams and run clinical trials to develop disease-modifying products
Phase 04-
Deliver
-
Commercialize and distribute proven treatments to help patients with significant diseases
Pipeline
Our platform is delivering:
4
subsidiaries
10
programs
4
clinical
programs
50k+
addressable
patients eligible to receive care
bottom of page